The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mostafa Adam S. since 2020.
This trader's CIK number is 1738081.
At the time of last reporting, Mostafa Adam S. was the Chief Financial Officer of X4 Pharmaceuticals, Inc. (stock ticker symbol XFOR).
Also see all insider trading activities at X4 Pharmaceuticals, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | XFOR | 0 | $0 | 74,773 | $33,946 | 0 | $0 |
| 2024 | XFOR | 0 | $0 | 310,866 | $201,181 | 0 | $0 |
| 2023 | XFOR | 0 | $0 | 329,758 | $277,745 | 0 | $0 |
| 2022 | XFOR | 0 | $0 | 24,307 | $0 | 0 | $0 |
| 2021 | XFOR | 0 | $0 | 18,890 | $110,752 | 0 | $0 |
| 2020 | XFOR | 0 | $0 | 12,559 | $92,297 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-24 | XFOR | Sale | 74,773 | .45 | 33,946 |
| 2024-10-07 | XFOR | Sale | 230,645 | .55 | 126,854 |
| 2024-03-11 | XFOR | Sale | 52,500 | .88 | 46,357 |
| 2024-02-12 | XFOR | Sale | 27,721 | 1.01 | 27,970 |
| 2023-11-01 | XFOR | Sale | 230,645 | .73 | 168,370 |
| 2023-06-30 | XFOR | Sale | 2,641 | 1.89 | 4,991 |
| 2023-06-23 | XFOR | Sale | 5,417 | 1.93 | 10,454 |
| 2023-06-15 | XFOR | Sale | 5,417 | 2.22 | 12,025 |
| 2023-06-15 | XFOR | Sale | 5,417 | 2.22 | 12,025 |
| 2023-03-10 | XFOR | Sale | 52,500 | .84 | 44,100 |
| 2023-02-13 | XFOR | Sale | 27,721 | .93 | 25,780 |
| 2022-08-17 | XFOR | Sale | 10,834 | .00 | 0 |
| 2022-06-30 | XFOR | Sale | 2,641 | .00 | 0 |
| 2022-06-24 | XFOR | Sale | 5,416 | .00 | 0 |
| 2022-06-16 | XFOR | Sale | 5,416 | .00 | 0 |
| 2021-08-17 | XFOR | Sale | 10,832 | 5.10 | 55,243 |
| 2021-06-30 | XFOR | Sale | 2,641 | 6.64 | 17,536 |
| 2021-06-24 | XFOR | Sale | 5,417 | 7.01 | 37,973 |
| 2020-09-21 | XFOR | Sale | 10,834 | 7.08 | 76,704 |
| 2020-06-30 | XFOR | Sale | 1,725 | 9.04 | 15,593 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mostafa Adam S. (Chief Financial Officer of X4 Pharmaceuticals, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.